The renal clear cell carcinoma immune landscape

Omar A Saad; Wei Tse Li; Aswini R Krishnan; Griffith C Nguyen; Jay P Lopez; Rana R McKay; Jessica Wang-Rodriguez; Weg M Ongkeko

doi:10.1016/j.neo.2021.12.007

The renal clear cell carcinoma immune landscape

Neoplasia. 2022 Feb;24(2):145-154. doi: 10.1016/j.neo.2021.12.007. Epub 2022 Jan 4.

Authors

Omar A Saad¹, Wei Tse Li², Aswini R Krishnan³, Griffith C Nguyen⁴, Jay P Lopez⁵, Rana R McKay⁶, Jessica Wang-Rodriguez⁷, Weg M Ongkeko⁸

Affiliations

¹ Department of Surgery, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: [email protected].
² Department of Surgery, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: [email protected].
³ Department of Surgery, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: [email protected].
⁴ Department of Surgery, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: [email protected].
⁵ Division of Hematology and Oncology, New York-Presbyterian/Weill Cornell Medical College, NY, USA.
⁶ Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA, USA. Electronic address: [email protected].
⁷ Veterans Administration Medical Center and Department of Pathology, University of California, San Diego, La Jolla, California 92161, USA. Electronic address: [email protected].
⁸ Department of Surgery, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: [email protected].

Abstract

A comprehensive evaluation of the clear cell renal cell carcinoma (ccRCC) immune landscape was found using 584 RNA-sequencing datasets from The Cancer Genome Atlas (TCGA), we identified 17 key dysregulated immune-associated genes in ccRCC based on association with clinical variables and important immune pathways. Of the numerous findings from our analyses, we found that several of the 17 key dysregulated genes are heavily involved in interleukin and NF-kB signaling and that somatic copy number alteration (SCNA) hotspots may be causally associated with gene dysregulation. More importantly, we also found that key immune-associated genes and pathways are strongly upregulated in ccRCC. Our study may lend novel insights into the clinical implications of immune dysregulation in ccRCC and suggests potential immunotherapeutic targets for further evaluation.

Keywords: Renal clear cell carcinoma; TCGA.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Carcinoma, Renal Cell / etiology*
Carcinoma, Renal Cell / pathology
Disease Susceptibility / immunology*
Gene Expression Regulation, Neoplastic
Humans
Immunity / genetics
Kidney Neoplasms / etiology*
Kidney Neoplasms / pathology
Signal Transduction

Substances

Biomarkers